CHINA CONTINUOUS GLUCOSE MONITORING DEVICES MARKET ANALYSIS

Market News

China Continuous Glucose Monitoring Devices Market: Key Developments

Major players in the market are focused on research and development activities to expand their product portfolio. For instance, according to an article published by the journal Biosensors and Bioelectronics on February 6, 2021, a study was carried out to integrate interstitial fluid extraction and glucose detection in one device for wearable non-invasive blood glucose sensors. The feasibility of these non-invasive glucose sensors was validated on porcine skin, nude mice, and humans. The blood glucose concentration calculated according to the response currents of the two-electrode sensors is consistent with that measured by the commercial glucose meter. Furthermore, the used textile-like electrodes provide non-invasive blood glucose sensors with excellent flexible and wearable properties, which make them promising to be integrated with other electronic units for monitor and management of human health.

On September 26, 2021, Nordic Semiconductor, Europe based semiconductor company, announced that SiBionics Shenzhen, a China-based healthcare technology developer, has selected Nordic’s nRF52832 Bluetooth Low Energy (Bluetooth LE) general purpose multiprotocol System-on-Chip (SoC) to provide the core processing power and wireless connectivity for its ‘GS1 Continuous Glucose Monitoring (CGM) System’. GS1 CGM System is designed to enable patients to continuously monitor and record their interstitial fluid glucose levels in real-time for up to fourteen days before replacement. The system automatically generates an ambulatory glucose profile (AGP) for reference during medical consultation, and it won’t affect the patient’s everyday activities such as swimming or exercise.

On March 22, 2022, WaveForm Technologies,Inc. U.S. based diabetes equipment supplier having a manufacturing facility in China, announced it received CE mark approval for two important product improvements to the WaveForm Cascade Continuous Glucose Monitoring (CGM) system. It can be now worn on the upper arm. In addition to the new sensor site, improvements to the sensor algorithm have reduced the number of calibrations required for the Cascade system to one every two days.

On August 3, 2022, Actxa Pte. Ltd, a Singapore based digital health company, and Joint Chinese Limited, a China-based manufacturer of smart healthcare devices signed a Memorandum of Understanding (“MOU”), to join hands in market penetration and expansion for Pre-M DiabetesTM, also known as the Non-Invasive Blood Glucose Monitoring technology.